07.01.2015 Views

Report 2008-2010

Report 2008-2010

Report 2008-2010

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

37<br />

The Laboratory of Immunology and Cell Biology consists of three research<br />

groups. In <strong>2008</strong>-<strong>2010</strong>, the research was focussed to the following<br />

topics: antigenic characterization of recombinant viral and bacterial<br />

proteins, development of monoclonal antibodies (Dr. A.Žvirblienė),<br />

regulation of gene expression by alternative splicing (Dr. A.Kanopka),<br />

molecular epidemiology of tuberculosis (Dr. P.Stakėnas).<br />

Antigenicity studies of recombinant viral proteins<br />

This work was aimed at evaluating the antigenic properties of yeast-expressed<br />

recombinant proteins that might be exploited as potential<br />

vaccines or diagnostic tools. Using different immunochemical assays,<br />

the antigenic structure of yeast-expressed nucleocapsid (N) proteins<br />

of paramyxoviruses, such as human parainfluenza virus type 3 (hPIV3)<br />

and Menangle virus has been investigated. Recombinant N proteins<br />

were expressed at the Laboratory of Eukaryote Gene Engineering.<br />

The yeast-expressed N proteins used in this study were self-assembled<br />

A<br />

into nucleocapsid-like structures (NLPs) similar to that of native virus.<br />

To identify B-cell epitopes, we have employed monoclonal antibodies<br />

(MAbs) raised against recombinant N proteins as well as human sera<br />

from virus-infected individuals. The localization of B-cell epitopes was<br />

studied using recombinant overlapping N protein fragments, PepScan<br />

analysis and competitive ELISAs. The majority of MAb epitopes were<br />

mapped within the C-termini of N proteins. Cross-inhibition studies<br />

with human sera demonstrated similar localization of B cell epitopes<br />

recognized by serum antibodies from naturally infected individuals,<br />

which revealed a clear antigenic similarity between recombinant and<br />

virus-derived N proteins. Our data suggest that different paramyxoviruses<br />

may contain highly conserved surface-exposed structures<br />

within the C-termini of N proteins that are well accessible to B cells<br />

and elicit antibody response. These findings may have important implications<br />

for the design of new vaccines and diagnostic reagents (Zvirbliene<br />

et al., Viral Immunol. 2009, Zvirbliene et al., Arch Virol. <strong>2010</strong>).<br />

B<br />

Figure 1. Immunochemical detection of virus-infected cells using monoclonal antibodies raised against recombinant N proteins of hPIV3 (A) and Menangle virus (B).<br />

Functional and immunological characterization of recombinant<br />

vaginolysin<br />

Vaginolysin (VLY) is the main virulence factor released by Gardnerella<br />

vaginalis. VLY is a protein toxin that acts as a hemolysin. It belongs to<br />

the group of cholesterol-dependent cytolysins (CDCs), a large family<br />

of related pore-forming toxins found in five different genera of Grampositive<br />

bacteria. Generation of MAbs against bacterial cytolysins may<br />

promote elucidation of the relationship between their structure and<br />

mode of action.<br />

In the current study, we have developed and characterized a panel of<br />

MAbs against recombinant VLY and demonstrated that several MAbs<br />

neutralize VLY in the in vitro hemolytic assay. By using a series of recombinant<br />

proteins we have studied the specificity of the MAbs and<br />

mapped the epitope recognized by the most potent neutralizing MAb.<br />

The epitope for this MAb was localized near the N-terminus of VLY<br />

and included the conserved motif (VAARMQYD, aa 189-196) supposed<br />

to be involved in VLY oligomerization. Furthermore, we have<br />

employed the MAbs in a sandwich ELISA for VLY quantitation. In conclusion,<br />

the MAbs described in the current study may be useful for<br />

structural and functional studies of VLY as well as immunodetection<br />

of VLY in biological specimens (Zvirbliene et al., Toxicon <strong>2010</strong>,<br />

PCT/LT2009/000005).<br />

This work was supported by the Lithuanian State Science and Studies<br />

Foundation/Lithuanian Science Council (grant No. N-17)<br />

Dr. M.Plečkaitytė and Master student J.Alesiūtė investigate immunochemical<br />

properties of vaginolysin<br />

Figure 2. Schematic representation of VLY domains (D1-D4). Dashed area indicates VLY region recognized by the neutralizing monoclonal antibody.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!